These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15316195)

  • 21. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma.
    Geremia I; Bansal R; Stamatialis D
    Acta Biomater; 2019 May; 90():100-111. PubMed ID: 30953798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of endotoxin antibody in long-term dialysis patients.
    Yamagami S; Adachi T; Sugimura T; Wada S; Kishimoto T; Maekawa M; Yoshimura R; Niwa M; Terano Y; Shaldon S
    Int J Artif Organs; 1990 Apr; 13(4):205-10. PubMed ID: 2115504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with the JMS fully automated dialysis machine.
    Tsuchiya S; Moriishi M; Takahashi N; Watanabe H; Kawanishi H; Kim ST; Masaoka K
    ASAIO J; 2003; 49(5):547-53. PubMed ID: 14524562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased dialyzer reuse with citrate dialysate.
    Ahmad S; Callan R; Cole J; Blagg C
    Hemodial Int; 2005 Jul; 9(3):264-7. PubMed ID: 16191076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 27. Dialyzer reuse--part II: advantages and disadvantages.
    Twardowski ZJ
    Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High-efficiency membranes and the dialysis solution].
    Agliata S; Airoldi G; Baroni A; Boschetti M; Schweiger K; Fortina F; Ragazzoni E; Cavagnino A
    Minerva Urol Nefrol; 1990; 42(1):39-42. PubMed ID: 2389221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis.
    Arizono K; Nomura K; Motoyama T; Matsushita Y; Matsuoka K; Miyazu R; Takeshita H; Fukui H
    Blood Purif; 2004; 22 Suppl 2():26-9. PubMed ID: 15655319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysate purification after introduction of automated hot water disinfection system to central dialysis fluid delivery system.
    Ogawa T; Matsuda A; Yamaguchi Y; Sasaki Y; Kanayama Y; Maeda T; Noiri C; Hasegawa H; Matsumura O; Mitarai T
    ASAIO J; 2012; 58(2):127-31. PubMed ID: 22370682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
    Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
    ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients.
    Yamagami S; Adachi T; Sugimura T; Kishimoto T; Maekawa M; Niwa M; Shaldon S
    ASAIO Trans; 1989; 35(3):331-3. PubMed ID: 2597475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
    Lonnemann G; Koch KM; Shaldon S; Dinarello CA
    J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study on the endotoxin and bacterial contamination in reverse osmosis water and dialysis fluids].
    Liu H; Li G; Zhang X; Duan X; Yao Y
    Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):806-9. PubMed ID: 11798721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo studies of dialysis-related endotoxemia and bacteremia.
    Bernick JJ; Port FK; Favero MS
    Nephron; 1981; 27(6):307-12. PubMed ID: 7266719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The level of endotoxins in hemodialysis water and dialysate in Lithuanian hemodialysis centers.
    Skarupskienė I; Bumblytė IA; Tamošaitis D; Venterienė J; Kuzminskis V
    Medicina (Kaunas); 2010; 46(8):556-60. PubMed ID: 20966633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of endotoxin in dialysis fluid from 39 dialysis units.
    Kulander L; Nisbeth U; Danielsson BG; Eriksson O
    J Hosp Infect; 1993 May; 24(1):29-37. PubMed ID: 8101200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of lipid A and Pseudomonas aeruginosa endotoxin from dialysis fluids by high-flux polysulfone ultrafilter (dialyzer).
    Rafiee-Tehrani M; Farrokhnia R; Falkenhagen D; Weber C
    PDA J Pharm Sci Technol; 1996; 50(5):306-10. PubMed ID: 8973116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.